Qi-En Wang

627 total citations
21 papers, 494 citations indexed

About

Qi-En Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Qi-En Wang has authored 21 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Qi-En Wang's work include Cancer Cells and Metastasis (6 papers), MicroRNA in disease regulation (3 papers) and FOXO transcription factor regulation (3 papers). Qi-En Wang is often cited by papers focused on Cancer Cells and Metastasis (6 papers), MicroRNA in disease regulation (3 papers) and FOXO transcription factor regulation (3 papers). Qi-En Wang collaborates with scholars based in United States, China and India. Qi-En Wang's co-authors include Altaf A. Wani, Gulzar Wani, Qianzheng Zhu, Nidhi Sharma, Chunhua Han, Jianying Zhang, Jianhong Chu, Jianhua Yu, Xiaoming He and Alo Ray and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Qi-En Wang

19 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qi-En Wang United States	11	331	225	99	84	63	21	494
Natalie McGregor United States	8	224 0.7×	240 1.1×	60 0.6×	140 1.7×	98 1.6×	8	504
Mansi Shah United States	12	231 0.7×	161 0.7×	45 0.5×	110 1.3×	108 1.7×	24	483
Mala K. Talekar United States	11	197 0.6×	203 0.9×	41 0.4×	63 0.8×	25 0.4×	17	372
Abilasha Rao‐Bhatia Canada	6	302 0.9×	157 0.7×	65 0.7×	95 1.1×	97 1.5×	6	509
Mark Wade United Kingdom	12	326 1.0×	140 0.6×	50 0.5×	56 0.7×	89 1.4×	24	478
Boris Gole Slovenia	12	282 0.9×	112 0.5×	27 0.3×	60 0.7×	102 1.6×	22	420
Sonia Brockway United States	7	300 0.9×	171 0.8×	28 0.3×	167 2.0×	91 1.4×	8	472
Mengchi Wang United States	12	395 1.2×	66 0.3×	43 0.4×	61 0.7×	88 1.4×	17	547
Ryan C. Chai Australia	12	299 0.9×	124 0.6×	54 0.5×	54 0.6×	91 1.4×	22	486
Yi Luan United States	10	335 1.0×	150 0.7×	23 0.2×	78 0.9×	71 1.1×	19	575

Countries citing papers authored by Qi-En Wang

Since Specialization

Citations

This map shows the geographic impact of Qi-En Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi-En Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi-En Wang more than expected).

Fields of papers citing papers by Qi-En Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi-En Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi-En Wang. The network helps show where Qi-En Wang may publish in the future.

Co-authorship network of co-authors of Qi-En Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qi-En Wang. A scholar is included among the top collaborators of Qi-En Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi-En Wang. Qi-En Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Zhaojun, Anqi Li, Deepika Singh, et al.. (2025). PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation. Journal of Clinical Investigation. 136(4).

Li, Na, et al.. (2025). Regulation of Cancer Stem Cells in the Tumor Microenvironment. PubMed. 2(4).

Pandey, Prashant, et al.. (2024). ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy. Life Sciences. 356. 123033–123033. 32 indexed citations

Bai, Xuetao, et al.. (2023). Abstract 2428: Cancer stem cells maintain stemness via autocrine activation of the IFN/JAK/STAT signaling pathway. Cancer Research. 83(7_Supplement). 2428–2428. 1 indexed citations

Cai, Shurui, Na Li, Xuetao Bai, et al.. (2022). ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transition. Theranostics. 12(16). 7051–7066. 23 indexed citations

Dorayappan, Kalpana Deepa Priya, Uksha Saini, Casey Cosgrove, et al.. (2021). Aberrant expression of TMEM205 signaling promotes platinum resistance in ovarian cancer: An implication for the antitumor potential of DAP compound. Gynecologic Oncology. 164(1). 136–145. 10 indexed citations

Duan, Wenrui, et al.. (2021). MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers. Scientific Reports. 11(1). 4420–4420. 3 indexed citations

Banerjee, Ananya, et al.. (2021). Abstract 3094: Estrogen receptor β agonist depletes ovarian cancer stem cells via repressing epithelial to mesenchymal transition. Cancer Research. 81(13_Supplement). 3094–3094. 1 indexed citations

Wang, Qi-En, Jing Yue, Xuan Zhou, et al.. (2020). Ouabain regulates kidney metabolic profiling in rat offspring of intrauterine growth restriction induced by low-protein diet. Life Sciences. 259. 118281–118281. 4 indexed citations

10.

Zhou, Xuan, Meihong Zheng, Qi-En Wang, et al.. (2020). Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients. International Journal of Hematology. 111(6). 761–770. 13 indexed citations

11.

Bai, Yongsheng, et al.. (2020). Computational identification of key pathways and differentially-expressed gene signatures in ovarian cancer stem cells. 1843–1848. 1 indexed citations

12.

Che, Lixiao, Xingyuan Yang, Chunmin Ge, et al.. (2019). Loss of BRUCE reduces cellular energy level and induces autophagy by driving activation of the AMPK-ULK1 autophagic initiating axis. PLoS ONE. 14(5). e0216553–e0216553. 14 indexed citations

13.

Srivastava, Amit Kumar, Asim Rizvi, Tiantian Cui, et al.. (2018). Depleting ovarian cancer stem cells with calcitriol. Oncotarget. 9(18). 14481–14491. 22 indexed citations

14.

Kong, Linghui, Qi-En Wang, Jiewen Jin, et al.. (2017). Insulin resistance enhances the mitogen-activated protein kinase signaling pathway in ovarian granulosa cells. PLoS ONE. 12(11). e0188029–e0188029. 11 indexed citations

15.

Gao, Li, Brittany Aguila, Mohammad Aminur Rahman, et al.. (2016). Rad51C-ATXN7 fusion gene expression in colorectal tumors. Molecular Cancer. 15(1). 47–47. 11 indexed citations

16.

Han, Jianfeng, Xilin Chen, Jianhong Chu, et al.. (2015). TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response. Cancer Research. 75(24). 5273–5282. 74 indexed citations

17.

Srivastava, Amit Kumar & Qi-En Wang. (2015). Targeting translesion synthesis to facilitate the eradication of ovarian cancer stem cells by platinum-based therapy. Molecular & Cellular Oncology. 3(1). e1043482–e1043482. 8 indexed citations

18.

Chu, Jianhong, Shun He, Youcai Deng, et al.. (2014). Genetic Modification of T Cells Redirected toward CS1 Enhances Eradication of Myeloma Cells. Clinical Cancer Research. 20(15). 3989–4000. 92 indexed citations

19.

Sharma, Nidhi, et al.. (2013). USP3 counteracts RNF168 via deubiquitinating H2A and γH2AX at lysine 13 and 15. Cell Cycle. 13(1). 106–114. 95 indexed citations

20.

Zhao, Qun, Qi-En Wang, Alo Ray, et al.. (2009). Modulation of Nucleotide Excision Repair by Mammalian SWI/SNF Chromatin-remodeling Complex. Journal of Biological Chemistry. 284(44). 30424–30432. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact